Aurobindo Pharma Faces Tax Department Demand For Refund Recovery Worth 1.7 Billion Rupees

Aurobindo Pharma Limited has announced that the Indian tax department has issued a demand for recovery of refunds totaling 1.7 billion rupees. The company confirmed the disputed amount in its regulatory communication, highlighting that the issue pertains to past tax assessments and is currently under dispute.  

The Hyderabad-based pharmaceutical giant stated that it is evaluating the demand and will pursue necessary legal remedies to safeguard shareholder interests. The disclosure comes as part of its compliance with stock exchange regulations, ensuring transparency for investors and stakeholders.  

Key highlights from the announcement include  

• Tax department demands recovery of refunds from Aurobindo Pharma  
• Disputed amount totals 1.7 billion rupees  
• Company confirms matter is under review and will pursue legal remedies  
• Disclosure made in regulatory filing to ensure transparency with shareholders  
• Issue pertains to past tax assessments under dispute  

Industry experts note that such tax-related disputes are not uncommon in India’s corporate sector, particularly in pharmaceuticals, where large-scale operations often involve complex compliance requirements. Aurobindo Pharma’s proactive disclosure reflects its commitment to regulatory compliance and investor communication.  

Sources: Aurobindo Pharma Regulatory Filing, Economic Times, Business Standard